SONOMA PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$1.10
-8.33%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-12.0%
3 months
-1.8%
6 months
-8.3%
1 year
-72.2%
Year to date
-69.8%
52-week range
$1.01 – $3.95
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$5.3M
P/E
-2.3
P/B
0.8
P/S
0.2
Revenue
$21.92M
Net income
-$2.26M
Diluted EPS
-1.22
Gross margin
38.90%
Net margin
-10.30%
Return on equity
-53.60%
Total debt
$739K
Cash
$5.34M
Free cash flow
-$2.66M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $6.41M | -$330K | 40.20% | -5.20% | -$651K |
| Mar 31, 2026 | $5.56M | -$581K | 39.20% | -10.40% | -$548K |
| Dec 31, 2025 | $4.35M | -$819K | 37.90% | -18.80% | -$811K |
| Sep 30, 2025 | $5.6M | -$534K | 37.80% | -9.50% | -$645K |
| Jun 30, 2025 | $4.02M | -$1.24M | 36.50% | -30.90% | -$2.12M |
| Mar 31, 2025 | $3.75M | -$776K | 40.70% | -20.70% | -$142K |
| Dec 31, 2024 | $3.56M | -$928K | 35.60% | -26.00% | $563K |
| Sep 30, 2024 | $3.58M | -$610K | 38.00% | -17.00% | $328K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent SNOA news
All market newsNo ticker-linked stories are in the current archive.